Medical Blister Aluminium Foil

Medical blister aluminium foil is a core consumable material for solid pharmaceutical dosage form packaging, serving as a crucial line of defense for ensuring drug stability due to its superior barrier properties. As a supplier deeply rooted in the export market, Haomei Aluminum understands the core demands of global pharmaceutical companies for packaging materials—resistance to moisture, أكسجين, وضوء, while also meeting compliance standards in multiple countries. حاليا, the global market is upgrading towards high-barrier and environmentally friendly materials, with aluminum foil self-sufficiency reaching 91%. Haomei الألومنيوم, with its compliance capabilities and quality control, has become a trusted partner for overseas pharmaceutical companies.

Products strictly adhere to international standards, with mainstream thicknesses covering 0.016-0.065mm, adaptable to different dosage form requirements. The base material uses pharmaceutical-grade alloys such as 8011, 8021, و 8079, with a surface cleanliness meeting or exceeding ISO 8573-1 Class 2, ensuring coating adhesion and heat-sealing strength. Widths can be customized from 100-1600mm to meet the production pace of high-speed blister packaging machines. Export products have all passed international certifications such as FDA 21 CFR Part 211 and EU GMP Annex 1, with batch-to-batch errors controlled within ±0.002mm.

Based on application scenarios, our medical رقائق الألومنيوم نفطة products are divided into three categories:

أول, PTP pharmaceutical aluminum foil, primarily made of 8011 أشابة, بسمك 0.016-0.04 ملم, suitable for ordinary tablets and capsules, المحاسبة أكثر 60% of exports.

ثانيا, cold-formed blister aluminum foil, using 8021-O state alloy, بسمك 0.04-0.065 ملم, suitable for high-end moisture-proof and light-proof pharmaceuticals.

الثالث, tropical aluminum foil, combining 8021 و 8079 alloys, for aluminum-plastic-aluminum composite packaging, primarily targeting high-end applications such as biological agents, with a gross profit margin exceeding 30%.

Haomei medical blister packaging aluminum foil achieves differentiated competitiveness through its core product strengths: أول, its nano-coating technology achieves a 99.99% antibacterial rate, with pinhole count controlled to ≤3 per square meter, far exceeding the industry average, thus building a solid protective barrier for pharmaceuticals. ثانيا, the base material uses high-purity pharmaceutical-grade alloys, combined with precision rolling processes, ensuring stable coating adhesion and heat-sealing strength, and is compatible with high-speed blister packaging machines for continuous production. الثالث, it supports full-dimensional customization, allowing for optimization of barrier formulations, adaptation to child-proof opening structures and printing needs for elderly medications, while also meeting compliance standards in multiple countries, making the product suitable for different market scenarios worldwide.

Medical blister aluminium foil widely covers packaging for chemical drugs, traditional Chinese medicine, health products, and vaccine excipients, with chemical drug tablets and capsules accounting for 76.3% of its applications. Export markets focus on Southeast Asia, Europe and the United States, and countries along the Belt and Road Initiative, adapting to scenarios such as COVID-19 test kits, chronic disease medications, and vaccine cold chain packaging. Optimized low-temperature resistant (performance retention rate ≥95% at -40℃) and moisture-proof formulas for different regional climates have won long-term cooperation from customers in tropical and cold regions, and the product repurchase rate remains among the top in the industry.